CARDIOVASCULAR RISK AND TYPE 2 DIABETES MELLITUS RISK IN OBESE CHILDREN

Session Name
HUMAN FACTOR IN THE USE OF DIABETES TECHNOLOGY
Session Type
E-POSTER VIEWING (EXHIBITION HOURS)
Date
20.02.2020, Thursday
Session Time
09:30 - 15:30
Channel
E-Poster Area
Lecture Time
10:18 - 10:19
Presenter
  • Michael Yafi, United States of America
Authors
  • Josue Maldonado, United States of America
  • Nunilo Rubio, United States of America
  • Michael Yafi, United States of America

Abstract

Background and Aims

Childhood obesity remains the most important risk factor of developing type 2 diabetes and cardiovascular diseases. In the U.S.A, the Center of Disease Control and Prevention (CDC) estimates that greater than one third of the children and adolescents were overweight or obese.

In recent years, cases of pediatric type 2 diabetes in children have been diagnosed more frequently at younger ages than previously seen.

Pediatric obesity and type 2 diabetes are more likely to continue into adulthood.

The objective of this study is to report the association of obesity in children 18 years old or younger with type 2 diabetes, dyslipidemia and hypertension.

Methods

The study population consisted of all patients seen in a pediatric endocrinology clinic. An analysis of ICD10 diagnosis codes was performed for a two- year period from 2015 to 2016, to evaluate the association of diagnoses of obesity and abnormal weight gain with type 2 diabetes and other co-morbidities.

Results

Of 189 overweight, obese or morbidly obese patients identified, twenty six patents (13%) had dyslipidemia, three (less than 1%) had type 2 diabetes and 3 (less than 1 %) had hypertension

Conclusions

Early diagnosis and management of diabetes, hypertension and dyslipidemia in obese children is essential. The pediatric obesity epidemic has allowed adult-type pathologies to evolve in the pediatric population.

Hide